Announcements Trials
Browse Landscape

Phase

Phase 2 400Phase 1 197Phase 1/2 138Phase 3 72Phase EARLY_PHASE1 18Phase NA 16Phase 2/3 16Phase 4 3

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Glioblastoma 2Oligodendroglioma 1Glioma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Temozolomide × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT00686725 2017-06-14

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Merck Sharp & Dohme LLC

Phase 4 Completed
99 enrolled 15 charts
CNS

Glioblastoma

NCT02343081 2015-04-02

Bioequivalence Study of Temozolomide in Patients With Primary Tumors of the Central Nervous System

Monte Verde SA

Phase 4 Completed
24 enrolled 13 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡